Last updated on July 2019

A Study to Evaluate SAGE-217 in Adult Subjects With Major Depressive Disorder

Brief description of study

This is a phase 3, open-label, 1-year study of the safety, tolerability, and need for re-treatment with SAGE-217 in adult subjects with major depressive disorder

Clinical Study Identifier: NCT03864614

Find a site near you

Start Over

Sage Investigational Site

Princeton, NJ United States
  Connect »